Everyone is welcome for a public lecture at UBC on Wednesday Jan 31 at 7PM, entitled “Can Immune Cells Really Cure Cancer?” by Dr. Denis Claude Roy, University of Montreal. The lecture will be held in the UBC Life Sciences Centre, 2350 Health Sciences Mall, Room LSC3, from 7-8PM.
Register at eventbrite or RSVP by email to: firstname.lastname@example.org
This is the second in a 5-part Killam Connection-sponsored public lecture series entitled “Stem Cells and Regenerative Medicine: What does the Future Hold?”
More info here.
Denis-Claude Roy’s research interests focus on cellular and immunological approaches to fight such blood cancers as leukemia and lymphoma, including the treatment of stem cell grafts to eliminate risks of graft rejection and optimize their anti-cancer activity. He has chaired 15 Phase I-II clinical trials at the national and international level, and significantly contributed to the development of all ATIR™ blood cancer products, Reviroc™ and Rhitol™.
Dr. Roy is Co-Director of the Cell FRSQ Network. He is also CEO of CellCAN Regenerative Medicine and Cell Therapy Network and CSO of the Centre for Commercialization of Cancer Immunotherapy (C3i). He is currently Director of Research for East-of-Montreal-CIUSSS, and Scientific Director of the Centre of Excellence for Cellular Therapy (CETC), Maisonneuve-Rosemont Hospital. He is also member of a working group on acute leukemia stem cell transplant, member of the Canadian Blood and Marrow Transplant Group and Clinical Trials, and member of the Canadian Network on stem cell research.